Category Archives: Stell Cell Research


Egg cells from Stell Cells: A breakthrough in fertility research | Bionic …

Its one of the basic truths about biology were all thought in high school: while men can produce a nearly infinite amount of sperm cells throughout their lifetime, women are born with a set number of egg cells and once they run out, well then thats that. Recent research by Jonathan Tilly of the Massachusetts General Hospital in Boston however, has suggested that egg cells can develop from a certain kind of egg-producing stem cells in mice.

Apart from rustling the fundaments of developmental biology, this discovery may also have very useful application in fertility treatments for women. Kutluk Oktay, reproductive biologist at the New York Medical College in Valhalla, compares these findings with discovering a planet in our solar system with a bacterium on it.

Like with many breakthroughs in science, it was not the original goal of the researches to overturn an established dogma. They just found something that didnt seem to stroke with the general consensus and decided to investigate further.

As mentioned before, the presence of egg producing stem cells was only proven in mice at first, and not a lot of people believed that the same kind of cells were also present in humans. Jonathan Tilly however, has shown that some stem cells are present in the ovaries of women, but it still remains to be seen if these stem cells can actually develop in fully functional reproductive cells. Tully remains positive however, that he can somehow control the biological clock.

Full article from Nature Medicine

Like Loading...

.

View post:
Egg cells from Stell Cells: A breakthrough in fertility research | Bionic ...

Schistosome stem cells could explain how the worms survive for so …

The parasites that cause schistosomiasis, one of the most common parasitic infections in the world, are notoriously long-lived. Researchers have now found stem cells inside the parasite that can regenerate worn-down organs, which may help explain how they can live for years or even decades inside their host.

Schistosomiasis is acquired when people come into contact with water infested with the larval form of the parasitic worm Schistosoma, known as schistosomes. Schistosomes mature in the body and lay eggs that cause inflammation and chronic illness. Schistosomes typically live for five to six years, but there have been reports of patients who still harbor parasites decades after infection.

According to new research from Howard Hughes Medical Institute (HHMI) investigator Phillip Newmark, collections of stem cells that can help repair the worms bodies as they age could explain how the worms survive for so many years. The new findings were published online on February 20, 2013, in the journal Nature.

The stem cells that Newmarks team found closely resemble stem cells in planaria, free-living relatives of the parasitic worms. Planaria rely on these cells, called neoblasts, to regenerate lost body parts. Whereas most adult stem cells in mammals have a limited set of possible fatesblood stem cells can give rise only to various types of blood cells, for example planarian neoblasts can turn into any cell in the worms body under the right circumstances.

Newmarks lab at the University of Illinois at Urbana-Champaign has spent years focused on planaria, so they knew many details about planarian neoblasts what they look like, what genes they express, and how they proliferate. They also knew that in uninjured planarians, neoblasts maintain tissues that undergo normal wear and tear over the worms lifetime.

We began to wonder whether schistosomes have equivalent cells and whether such cells could be partially responsible for their longevity, says Newmark.

Following this hunch, and using what they knew about planarian neoblasts, post-doctoral fellow Jim Collins, Newmark, and their colleagues hunted for similar cells in Schistosoma mansoni, the most widespread species of human-infecting schistosomes.

Their first step was to look for actively dividing cells in the parasites. To do this, they grew worms in culture and added tags that would label newly replicated DNA as cells prepare to divide; this label could later be visualized by fluorescence. Following this fluorescent tag, they saw a collection of proliferating cells inside the worms body, separate from any organs.

The researchers isolated those cells from the schistosomes and studied them individually. They looked like typical stem cells, filled with a large nucleus and a small amount of cytoplasm that left little room for any cell-type-specific functionality. Newmarks lab observed the cells and found that they often divided to give rise to two different cells: one cell that continued dividing, and another cell that did not.

One feature of stem cells, says Newmark, is that they make more stem cells; furthermore, many stem cells undergo asymmetric division. The schistosomes cells were behaving like stem cells in these respects. The other characteristic of stem cells is that they can differentiate into other cell types.

See original here:
Schistosome stem cells could explain how the worms survive for so ...

Florida Hospital Pepin Heart Institute, USF partner … – Stem Cell Cafe

Feb 23

Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into a clinical trial testing a novel gene therapy for the treatment of heart failure after ischemic injury. The therapy may promote the regeneration of heart tissue by encouraging the body to deploy more stem cells to the injury site.

Dr. Charles Lambert, Medical Director of Florida Hospital Pepin Heart Institute and Dr. Leslie Miller, Director of the USF Heart Institute, are leading the way for the randomized, placebo-controlled trial which spans 10 sites across the United States. The study, called the STOP-HF, will enroll 90 patients nationwide.

Heart failure (HF) can occur when the muscles of the heart become weakened and cannot pump blood sufficiently throughout the body. The injury is most often caused by inadequate blood flow to the heart resulting from chronic or acute cardiovascular disease, including heart attacks. Considerable scientific evidence has emerged over the past decade demonstrating the high therapeutic potential of regenerative medicine for a host of diseases. Heart failure is a leading cause of death, disability and hospitalization.

Dr. Charles Lambert is performing the gene therapy by direct injection into the heart using an investigational system in the catheterization laboratories at Florida Hospital Pepin Heart Institute.

Pepin Heart and Dr. Kiran C. Patel Research Institute and USF are exploring and conducting leading-edge research to develop break-through treatments long before they are even available in other facilities, Dr. Lambert said. Stem cells have the unique ability to develop into many different cell types, and in many tissues serve as an internal repair system, dividing essentially without limit to replenish other cells. This trial is unique in that it uses gene therapy to turn on a process leading to cell regeneration rather than simply administering stem cells directly.

The Pepin Heart Institute has a history of cardiovascular stem cell research as part of the NIH sponsored Cardiac Cell Therapy Research Network (CCTRN) as well as other active cell therapy trials. Locally, the STOP-HF trial is the first of several regenerative medicine clinical trials teaming the USF Heart Institute with Florida Hospital Pepin Heart Institute, which is adjacent to the USF Health campus.

Follow this link: Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

More here:
Florida Hospital Pepin Heart Institute, USF partner ... - Stem Cell Cafe

Cell therapy: New mouse model promises to advance research on …

Feb. 21, 2013 Cell therapy is a promising alternative to tissue and organ transplantation for diseases that are caused by death or poor functioning of cells. Considering the ethical discussions surrounding human embryonic stem cells, a lot is expected of the so-called induced pluripotent stem cells (iPS cells). However, before this technique can be applied effectively, a lot of research is required into the safety and efficacy of such iPS cells. VIB scientists associated to the UGent have developed a mouse model that can advance this research to the next step.

Lieven Haenebalcke (VIB/UGent): iPS cells have enormous therapeutic potential, but require more thorough testing before they can be used for such purposes. Using our new mouse model, we can study which mechanisms determine the identity of a cell. This knowledge is essential before we can use cell therapy for regenerative medicine.

Jody Haigh (VIB/UGent): If we want to give cell therapy a future, then we must continue this type of research and invest in the further development of such technologies. This will result in an improved insight into cellular identity and in the long term safer options of applying iPS cells or cells derived from iPS cells in clinical studies.

Cell therapy replacing cells to provide a cure

Cell therapy is the replacement of lost or poorly functioning cells in patients. For example, such cell therapies could be used to repair the heart muscle after a heart attack, joints affected by arthritis, the pancreas in diabetes or the spine in certain forms of paralysis. This requires cells that are able to multiply in the laboratory and that can be converted to healthy cells of the desired cell type. Human embryonic stem cells meet these criteria, but they are ethically controversial.

iPS cells a promising alternative to embryonic stem cells

Shinya Yamanaka recently developed a fairly simple method to reprogram differentiated cells such as skin cells back to stem cells, so-called induced pluripotent stem cells (iPS cells). This earned him the Nobel Prize for Medicine in 2012 (shared with John Gurdon). These iPS cells can be generated using only 4 reprogramming factors.

As is the case with embryonic stem cells, these iPS cells can be used to produce other cell types, such as heart muscle cells or nerve cells. They can also be cultured indefinitely and there are no ethical objections as they are not obtained from human embryos left over after IVF, but from adult individuals. Furthermore, iPS cells are obtained from the patient and this reduces the risk of rejection during therapeutic applications.

Essential research possible

Before iPS cells can be used effectively and safely as a therapy, it is essential that we gain clear insight into which molecular mechanisms determine the identity of a cell; why and how a cell develops into for example a heart muscle cell, a nerve cell or a blood cell. In order to do so, Lieven Haenebalcke and Jody Haigh have developed a mouse model that will enable them to conduct this research. They succeeded in creating iPS cells from a variety of mouse cells. Furthermore, the new model allows the investigators to replace the 4 reprogramming factors in these iPS cells efficiently with specific genes in order to create targeted different cell types, such as functional heart muscle cells.

See more here:
Cell therapy: New mouse model promises to advance research on ...

Market Research Report — Therapeutic … – Stem Cell Cafe

ROCKVILLE, MD(Marketwire Feb 21, 2013) MarketResearch.com has announced the addition of the market research report Complete 2012-13 Induced Pluripotent Stem Cell Industry Report to their product offering.

iPSCs are adult stem cells that have been transformed into embryotic-like stem cells through the manipulation of gene expression and similar methods. Despite some initial concerns, induced pluripotent stem cells (iPSC) are now sold by more than half (53.4%) of U.S. research product companies and 38.7% of research product companies worldwide.

It is clear that iPSC products are in high demand within the scientific community. Currently, it is difficult for stem cell research product suppliers, like BD BioSciences, Life Technologies, and others, to know what products iPSC scientists will demand in 2013 and beyond. The needs of scientists are constantly changing, so this market intelligence report reveals profitable opportunities for providers of iPSC research products to pursue, says BioInformant.

For the past five decades, stem cell research has provided insights to the inner workings of the body and cell regeneration. Therapeutic applications of iPSCs represent the future of medicine, says BioInformant. The scientific community believes that one day stem cell research will assist in finding viable treatments for crippling diseases such as Parkinsons, Alzheimers, spinal cord injuries and more.

For more information, visit http://www.marketresearch.com/land/product.asp?productid=7242167&progid=85189

Follow us on Facebook http://www.facebook.com/marketresearchdotcom Follow us on Twitter http://www.twitter.com/marketresearch_

About BioInformant WorldWide, LLC

BioInformant Worldwide, LLCis a global leader in stem cell industry data.As a specialty research company, BioInformant uses technology to track and identify profitable opportunities in stem cell product markets and provides this data to clients that prioritize industry dominance.

About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the worlds most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.coms Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit http://www.marketresearch.com.

Read this article:
Market Research Report — Therapeutic ... - Stem Cell Cafe

Regenerative medicine and Stem cells Partnering Terms and …

Feb 19

NEW YORK, Feb. 19, 2013 /PRNewswire/ Reportlinker.com announces that a new market research report is available in its catalogue:

Regenerative medicine and Stem cells Partnering Terms and Agreements http://www.reportlinker.com/p01098514/Regenerative-medicine-and-Stem-cells-Partnering-Terms-and-Agreements.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

The Regenerative Medicine and Stem Cells Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the Regenerative medicine and Stem cells partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in regenerative medicine and stem cells deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells

The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors regenerative medicine and stem cells technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest regenerative medicine and stem cells agreements including cell therapy agreements announced in the healthcare sector.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all regenerative medicine and stem cells partnering deals announced since 2008 including financial terms where available including over 550 links to online deal records as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

Go here to read the rest:
Regenerative medicine and Stem cells Partnering Terms and ...

Signaling factors may be key to stem cells’ healing abilities …

CLEVELAND, Ohio Weve all heard of some of the amazing potential uses of stem cells: growing new tissues and organs for transplant, treating degenerative conditions such as multiple sclerosis and heart failure or safely testing new cancer drugs.

But much of the promise of future therapies depends on overcoming some significant technical hurdles and knowledge gaps.

One of those hurdles, understanding how stem cells heal injury, is now a lot smaller thanks to some cool basic-science research recently reported from a lab at Rosalind Franklin University of Medicine and Science in Chicago.

Using adult human stem cells typically found in the bone marrow, called mesenchymal stem cells, or MSCs, the Chicago team discovered that the stem cells promote healing in diabetic ulcers by signaling existing cells in the area to turn on the natural repair process that can be inhibited in people with the disease.

The team, led by Daniel Peterson, director of the Center for Stem Cell and Regenerative Medicine at the Chicago Medical School, performed the experiment in mice. Their study was published in Stem Cells Translational Medicine.

Although MSCs have come to be regarded as a cure-all for tissue injury, researchers have only recently started to gain even the smallest clue as to how they work.

This is a problem in the whole MSC field, Peterson said. In most studies, he said, the cells are injected into the bloodstream, and then disappear, making it difficult to understand how they work.

What happens is that they kind of get filtered out into the lungs, and where theyre getting into any tissue is a bit of a mystery, he said.

To avoid that problem, Petersons team applied the MSCs topically to a diabetic wound on the backs of lab mice. Even then, though, they couldnt be sure that the MSCs werent traveling through the mouses body and having a systemic effect. So a second wound on the mouses back, untreated with the MSCs, acted as a control. If there were any systemic healing effect, the untreated wound would get better. If the effect were local only, it wouldnt.

Even when applied topically, the MSCs disappeared quickly, Peterson said. But the mice healed only in the area where the MSCs were applied, not in the other wound. And levels of several types of molecules that are key to signaling and triggering the healing response called Wnt3a, VEGF and PDGFR-alpha rose in the treated area, suggesting that the MSCs recruited the mouses own stem cells in the vicinity to do the repair work.

See the original post:
Signaling factors may be key to stem cells' healing abilities ...

Fish stem cells could light the way to optical breakthroughs – Stem …

A small, stripy fish about the length of a Brazil nut may hold the key to treating human vision loss, following a discovery by the universitys Allison Lab that could see fish stem cells helping humanity.

Zebrafish can selectively repair light-sensitive cells in their retinas. These cells, called cones, are what humans rely on for daytime vision and colour perception. Unlike humans, zebrafish have specialized stem cells in their eyes that allow them to repair these cones when necessary.

Alternatively, when humans suffer retinal damage their eyes cannot recuperate something that could change in light of this new research.

Understanding how to make cones out of stem cells will facilitate therapies to prevent and/or reverse vision loss, explained Michle DuVal, a graduate student and team member at the Allison Lab, in an email interview.

The regenerative response that naturally occurs in zebrafish eyes is incredibly refined.

But the move from tiny fish to humans can get complicated. Limited industry involvement, scant funding and the difficulty of running clinical trials all pose threats to the future of stem cell research especially on the national level.

There are a lot of things going on very actively in other corners of the world, and not so much in Canada, said Tania Bubela, an associate professor at the School of Public Health who has studied stem cells.

One of the impediments is the availability of good manufacturing practice (GMP) materials to actually put into patients.

The increased focus on moving from animal models to clinical trials signals a positive change in the field of stem cell research, according to Timothy Caulfield, Canada Research Chair in Health Law and Policy and research director in the Law Faculty.

When stem cells first emerged in the late 90s, the focus was around the controversial nature of embryonic stem cell research, Caulfield said.

Read more:
Fish stem cells could light the way to optical breakthroughs – Stem ...

Scientists Say 3D Printing Can Create Stem Cells – Video – Stem …

Feb 07

Scientists Say 3D Printing Can Create Stem Cells Scientists say that 3D printing can create stem cells. Stem cells can now be produced using a form of 3D printing technology. (1,1,1) Developed by scientists from Heriot Watt University in Edinburgh, Scotland(1,8,1) the 3D printing technology is capable of making embryonic stem cells that can differentiate into any other kind of cell in the human body. (2,9,1) 3D printing has been used in various different industries, (2,1,1) but this is the first time that a human embryonic stem cell has been created this way. According to BBC News, Jason King, business development manager of stem cell biotech company Roslin Cellab, which took part in the research, (1,15,1) said: This is a scientific development which webelieve will have immensely valuable long-term implications for reliable, animal-free, drug testing, and, in the longer term, to provide organs for transplant on demand, without the need for donation and without the problems of immune suppression and potential organ rejection. The 3D printers make dots containing up to five stem cells from cultures that are floating in a bio ink. The printing process did not appear to damage the cells as researchers found that 99 percent of the cells remained usable. What do you think? Is this kind of stem cell technology development a step in the right direction?

By: GeoBeatsNews

See the article here: Scientists Say 3D Printing Can Create Stem Cells Video

Link:
Scientists Say 3D Printing Can Create Stem Cells – Video – Stem ...

Monell scientists identify taste stem cells on the tongue – Stem Cell …

Thediscovery of until now elusive taste stem cells on the tongue will help researchers and industry better understand the complexities of human taste, say researchers.

The breakthrough, byresearchers at the Monell Chemical Sciences Center, USA, will help to develop new techniques to grow and manipulate fully functional taste cells for use in research and clinical treatments, say thescientists behind the finding.

Writing in the journal Stem Cells,the Monell team explains that for decades taste scientists have attempted to identify the stem or progenitor cells that spawn the different taste receptor cells. This elusive challenge also sought to establish whether one, or several, progenitors were involved, and where they were located, they said.

Led by senior author Dr Peihua Jiang, the research team said that the identification of the location and certain genetic characteristics of taste stem cells on the tongue will kick-start research that better understands the make-up of human taste, and could someday help treat clinical taste dysfunctions.

This is just the tip of the iceberg, said Jiang. Identification of these cells opens up a whole new area for studying taste cell renewal, and contributes to stem cell biology in general.

Cancer patients who have taste loss following radiation to the head and neck and elderly individuals with diminished taste function are just two populations who could benefit from the ability to activate adult taste stem cells, explained Dr Robert Margolskee, who also worked on the study.

Tasty findings

The team explained that taste cells are located in clusters called taste buds, which in turn are found in papillae, the raised bumps visible on the tongues surface. In these structures, there are two types of taste cells that contain the chemical receptors that initiate perception of sweet, bitter, umami, salty, and sour taste qualities while a third type appears to serve as a supporting cell.

A remarkable characteristic of these sensory cells is that they regularly regenerate, said the researchers. All three taste cell types undergo frequent turnover, with an average lifespan of 10-16 days. As such, new taste cells must constantly be regenerated to replace cells that have died.

Read more from the original source: Monell scientists identify taste stem cells on the tongue

The rest is here:
Monell scientists identify taste stem cells on the tongue – Stem Cell ...